AZN financials
AstraZeneca (AZN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
AZN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $58.74B | $48.11B | $13.74B | $10.26B | 6.54 |
| 2024 | $54.07B | $43.87B | $10.00B | $7.04B | 4.50 |
| 2023 | $45.81B | $37.54B | $8.19B | $5.96B | 3.81 |
| 2022 | $44.35B | $31.96B | $3.76B | $3.29B | 2.11 |
| 2021 | $37.42B | $24.98B | $1.06B | $112.00M | 0.08 |
| 2020 | $26.62B | $21.32B | $5.16B | $3.20B | 2.44 |
- AZN revenue was $58.74B in fiscal 2025, net income $10.26B.
Updated 2026-11-02 19:55 UTC